Langerhans cell histiocytosis pathophysiology

Revision as of 19:07, 21 December 2015 by Nawal Muazam (talk | contribs)
Jump to navigation Jump to search

Langerhans cell histiocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Langerhans cell histiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Langerhans cell histiocytosis pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Langerhans cell histiocytosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Langerhans cell histiocytosis pathophysiology

on Langerhans cell histiocytosis pathophysiology

Langerhans cell histiocytosis pathophysiology in the news

Blogs on Langerhans cell histiocytosis pathophysiology

Directions to Hospitals Treating Langerhans cell histiocytosis

Risk calculators and risk factors for Langerhans cell histiocytosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Pathophysiology

Pathogenesis

Genetics

Associated Conditions

Gross Pathology

Microscopic Pathology

The disease spectrum results from clonal accumulation and proliferation of cells resembling the epidermal dendritic cells called langerhans cells, hence sometimes called dendritic cell histiocytosis. These cells in combination with lymphocytes, eosinophils and normal histiocytes form typical LCH lesion that can be found in almost any organ[1].

There are three types of histiocytoses[2]1. malignant (true histiocytic lymphomas) 2. "reactive" (benign histiocytoses) 3. Langerhans Cell Histiocytosis

"Reactive" in this context indicates that the abnormality may be due to a physiological reaction to infection. For example leukocytosis (proliferation of white blood cells) is a normal reaction to infection, and "histiocytes" are developmentally related to white blood cells (see article hematopoiesis).

Langerhans Cell Histiocytoses are traditionally divided into three groups:[2]

  • Unifocal (aka "Eosinophilic granuloma"): a slowly progressing disease, characterized by an expanding proliferation of Langerhans cells in various bones, skin, lungs or stomach.
  • Multifocal unisystem: characterized by fever and diffuse eruptions, usually on the scalp and in the ear canals, as well as bone lesions. Mostly seen in children. In 50% of cases the stalk of the pituitary gland is involved, leading to diabetes insipidus. The triad of diabetes insipidus, proptosis, and lytic bone lesions is known as Hand-Schuller-Christian triad
  • Multifocal multisystem (Letterer-Siwe disease): a rapidly progressing disease where Langerhans cells proliferate in many tissues. It is mostly seen in children under age 2, and the prognosis is poor: even with aggressive chemotherapy, the 5-year survival is only 50%.

Pulmonary Langerhans cell histiocytosis (PLCH) is a smoking-related interstitial lung disease, used to be considered a benign condition in adults, long term complications like pulmonary hypertension is becoming increasingly recognized.

References

  1. Makras P, Papadogias D, Kontogeorgos G, Piaditis G, Kaltsas G (2005). "Spontaneous gonadotrophin deficiency recovery in an adult patient with Langerhans cell histiocytosis (LCH)". Pituitary. 8 (2): 169–74. PMID 16379033.
  2. 2.0 2.1 Cotran, Ramzi S.; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Robbins, Stanley L. (2005). Robbins and Cotran pathologic basis of disease. St. Louis, Mo: Elsevier Saunders. pp. 701-. ISBN 0-8089-2302-1.


Template:WikiDoc Sources